Detalhe da pesquisa
1.
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.
Am J Hematol
; 89(4): 399-403, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375467
2.
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia.
Leuk Lymphoma
; 59(7): 1659-1665, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29179634